Arsanis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.arsanis.com
Clinical Trials
12
Active:9
Completed:0
Trial Phases
2 Phases
Phase 1:9
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
9 (75.0%)Phase 2
3 (25.0%)Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
Phase 2
Terminated
- Conditions
- Pneumonia, Ventilator-associatedPneumonia, Staphylococcal
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Arsanis, Inc.
- Target Recruit Count
- 155
- Registration Number
- NCT02940626
- Locations
- 🇺🇦
Research Site, Lviv, Ukraine
🇦🇹Research Site 040-001, Wien, Austria
🇦🇹Research Site 040-002, Wien, Austria
News
No news found